407 related articles for article (PubMed ID: 27716388)
1. The genetics of breast cancer risk in the post-genome era: thoughts on study design to move past BRCA and towards clinical relevance.
Skol AD; Sasaki MM; Onel K
Breast Cancer Res; 2016 Oct; 18(1):99. PubMed ID: 27716388
[TBL] [Abstract][Full Text] [Related]
2. Gene analysis techniques and susceptibility gene discovery in non-BRCA1/BRCA2 familial breast cancer.
Aloraifi F; Boland MR; Green AJ; Geraghty JG
Surg Oncol; 2015 Jun; 24(2):100-9. PubMed ID: 25936246
[TBL] [Abstract][Full Text] [Related]
3. Genetic risk of breast cancer.
Nasir A; Shackelford RE; Anwar F; Yeatman TJ
Minerva Endocrinol; 2009 Dec; 34(4):295-309. PubMed ID: 20046159
[TBL] [Abstract][Full Text] [Related]
4. BRCA and beyond: a genome-first approach to familial breast cancer risk assessment.
Trainer AH; Thompson E; James PA
Discov Med; 2011 Nov; 12(66):433-43. PubMed ID: 22127114
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer genes: beyond BRCA1 and BRCA2.
Filippini SE; Vega A
Front Biosci (Landmark Ed); 2013 Jun; 18(4):1358-72. PubMed ID: 23747889
[TBL] [Abstract][Full Text] [Related]
6. The impact of next generation sequencing on the analysis of breast cancer susceptibility: a role for extremely rare genetic variation?
Hilbers FS; Vreeswijk MP; van Asperen CJ; Devilee P
Clin Genet; 2013 Nov; 84(5):407-14. PubMed ID: 24025038
[TBL] [Abstract][Full Text] [Related]
7. A Review of Whole-Exome Sequencing Efforts Toward Hereditary Breast Cancer Susceptibility Gene Discovery.
Chandler MR; Bilgili EP; Merner ND
Hum Mutat; 2016 Sep; 37(9):835-46. PubMed ID: 27226120
[TBL] [Abstract][Full Text] [Related]
8. Common low-penetrance risk variants associated with breast cancer in Polish women.
Ledwoń JK; Hennig EE; Maryan N; Goryca K; Nowakowska D; Niwińska A; Ostrowski J
BMC Cancer; 2013 Oct; 13():510. PubMed ID: 24171766
[TBL] [Abstract][Full Text] [Related]
9. Identifying breast cancer susceptibility genes - a review of the genetic background in familial breast cancer.
Wendt C; Margolin S
Acta Oncol; 2019 Feb; 58(2):135-146. PubMed ID: 30606073
[TBL] [Abstract][Full Text] [Related]
10. Genetic susceptibility to breast cancer.
Mavaddat N; Antoniou AC; Easton DF; Garcia-Closas M
Mol Oncol; 2010 Jun; 4(3):174-91. PubMed ID: 20542480
[TBL] [Abstract][Full Text] [Related]
11. Oral contraceptive use and BRCA penetrance: a case-only study.
Pasanisi P; Hédelin G; Berrino J; Chang-Claude J; Hermann S; Steel M; Haites N; Hart J; Peled R; Gafà L; Leggio L; Traina A; Amodio R; Primic-Zakelj M; Zadnik V; Veidebaum T; Tekkel M; Berrino F
Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2107-13. PubMed ID: 19549808
[TBL] [Abstract][Full Text] [Related]
12. A role for common genomic variants in the assessment of familial breast cancer.
Sawyer S; Mitchell G; McKinley J; Chenevix-Trench G; Beesley J; Chen XQ; Bowtell D; Trainer AH; Harris M; Lindeman GJ; James PA
J Clin Oncol; 2012 Dec; 30(35):4330-6. PubMed ID: 23109704
[TBL] [Abstract][Full Text] [Related]
13. Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study.
Antoniou AC; Pharoah PD; McMullan G; Day NE; Ponder BA; Easton D
Genet Epidemiol; 2001 Jul; 21(1):1-18. PubMed ID: 11443730
[TBL] [Abstract][Full Text] [Related]
14. Characterization of BRCA1 and BRCA2 mutations in a large United States sample.
Chen S; Iversen ES; Friebel T; Finkelstein D; Weber BL; Eisen A; Peterson LE; Schildkraut JM; Isaacs C; Peshkin BN; Corio C; Leondaridis L; Tomlinson G; Dutson D; Kerber R; Amos CI; Strong LC; Berry DA; Euhus DM; Parmigiani G
J Clin Oncol; 2006 Feb; 24(6):863-71. PubMed ID: 16484695
[TBL] [Abstract][Full Text] [Related]
15. BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes.
Berry DA; Iversen ES; Gudbjartsson DF; Hiller EH; Garber JE; Peshkin BN; Lerman C; Watson P; Lynch HT; Hilsenbeck SG; Rubinstein WS; Hughes KS; Parmigiani G
J Clin Oncol; 2002 Jun; 20(11):2701-12. PubMed ID: 12039933
[TBL] [Abstract][Full Text] [Related]
16. Germline DNA variations in breast cancer predisposition and prognosis: a systematic review of the literature.
Sapkota Y
Cytogenet Genome Res; 2014; 144(2):77-91. PubMed ID: 25401968
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic analysis of familial breast cancer: comparison of BRCAx tumors with BRCA1-, BRCA2-carriers and non-familial breast cancer.
Aloraifi F; Alshehhi M; McDevitt T; Cody N; Meany M; O'Doherty A; Quinn CM; Green AJ; Bracken A; Geraghty JG
Eur J Surg Oncol; 2015 May; 41(5):641-6. PubMed ID: 25736863
[TBL] [Abstract][Full Text] [Related]
18. Familial concordance of breast cancer pathology as an indicator of genotype in multiple-case families.
Balleine RL; Provan PJ; Pupo GM; Pathmanathan N; Cummings M; Farshid G; Salisbury EL; Bilous AM; Byth K; ; Mann GJ
Genes Chromosomes Cancer; 2010 Dec; 49(12):1082-94. PubMed ID: 20815029
[TBL] [Abstract][Full Text] [Related]
19. Whole exome sequencing suggests much of non-BRCA1/BRCA2 familial breast cancer is due to moderate and low penetrance susceptibility alleles.
Gracia-Aznarez FJ; Fernandez V; Pita G; Peterlongo P; Dominguez O; de la Hoya M; Duran M; Osorio A; Moreno L; Gonzalez-Neira A; Rosa-Rosa JM; Sinilnikova O; Mazoyer S; Hopper J; Lazaro C; Southey M; Odefrey F; Manoukian S; Catucci I; Caldes T; Lynch HT; Hilbers FS; van Asperen CJ; Vasen HF; Goldgar D; Radice P; Devilee P; Benitez J
PLoS One; 2013; 8(2):e55681. PubMed ID: 23409019
[TBL] [Abstract][Full Text] [Related]
20. Familial breast cancer.
Lalloo F; Evans DG
Clin Genet; 2012 Aug; 82(2):105-14. PubMed ID: 22356477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
